Skrzypiec-Spring, M.; Kaczorowski, M.; Rak-Pasikowska, A.; Sapa-Wojciechowska, A.; Kujawa, K.; Żuryń, A.; Bil-Lula, I.; Hałoń, A.; Szeląg, A.
RhoA/ROCK Pathway Is Upregulated in Experimental Autoimmune Myocarditis and Is Inhibited by Simvastatin at the Stage of Myosin Light Chain Phosphorylation. Biomedicines 2024, 12, 596.
https://doi.org/10.3390/biomedicines12030596
AMA Style
Skrzypiec-Spring M, Kaczorowski M, Rak-Pasikowska A, Sapa-Wojciechowska A, Kujawa K, Żuryń A, Bil-Lula I, Hałoń A, Szeląg A.
RhoA/ROCK Pathway Is Upregulated in Experimental Autoimmune Myocarditis and Is Inhibited by Simvastatin at the Stage of Myosin Light Chain Phosphorylation. Biomedicines. 2024; 12(3):596.
https://doi.org/10.3390/biomedicines12030596
Chicago/Turabian Style
Skrzypiec-Spring, Monika, Maciej Kaczorowski, Alina Rak-Pasikowska, Agnieszka Sapa-Wojciechowska, Krzysztof Kujawa, Agnieszka Żuryń, Iwona Bil-Lula, Agnieszka Hałoń, and Adam Szeląg.
2024. "RhoA/ROCK Pathway Is Upregulated in Experimental Autoimmune Myocarditis and Is Inhibited by Simvastatin at the Stage of Myosin Light Chain Phosphorylation" Biomedicines 12, no. 3: 596.
https://doi.org/10.3390/biomedicines12030596
APA Style
Skrzypiec-Spring, M., Kaczorowski, M., Rak-Pasikowska, A., Sapa-Wojciechowska, A., Kujawa, K., Żuryń, A., Bil-Lula, I., Hałoń, A., & Szeląg, A.
(2024). RhoA/ROCK Pathway Is Upregulated in Experimental Autoimmune Myocarditis and Is Inhibited by Simvastatin at the Stage of Myosin Light Chain Phosphorylation. Biomedicines, 12(3), 596.
https://doi.org/10.3390/biomedicines12030596
